Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Roivant Sciences Ltd. Common Shares — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.45 (market cap $4.59B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 5.4× Definium Therapeutics Inc. Common Shares's market cap, and Roivant Sciences Ltd. Common Shares is more actively traded (6,279,442 versus 2,103,937). Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| DFTX | ROIV | |
|---|---|---|
Market Cap | $4.59B | $24.72B |
Volume | 2,103,937 | 6,279,442 |
Sector | Health | Health |
52-Week High | $48.45 | $41.81 |
52-Week Low | $10.68 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $20.99B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
